- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Norwegian Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Results
17
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
17 companies
Vistin Pharma
Market Cap: NOK 1.1b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 24.50
7D
0.8%
1Y
12.4%
Photocure
Market Cap: NOK 1.6b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 61.00
7D
-3.5%
1Y
25.8%
PCI Biotech Holding
Market Cap: NOK 55.8m
A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.
PCIB
NOK 1.50
7D
6.0%
1Y
-16.0%
Hofseth BioCare
Market Cap: NOK 719.4m
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States.
HBC
NOK 1.75
7D
-1.7%
1Y
-16.7%
Lytix Biopharma
Market Cap: NOK 640.3m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 9.38
7D
5.4%
1Y
-14.7%
Thor Medical
Market Cap: NOK 840.1m
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 2.38
7D
-4.6%
1Y
132.9%
EXACT Therapeutics
Market Cap: NOK 169.5m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 2.68
7D
-9.5%
1Y
-60.0%
BerGenBio
Market Cap: NOK 45.7m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway.
BGBIO
NOK 1.17
7D
0.7%
1Y
-89.9%
Circio Holding
Market Cap: NOK 66.3m
A biotechnology company, develops novel circular RNA and immunotherapy medicines.
CRNA
NOK 0.63
7D
1.3%
1Y
-64.1%
Norda
Market Cap: NOK 411.1m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 80.10
7D
0%
1Y
93.5%
ArcticZymes Technologies
Market Cap: NOK 978.0m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally.
AZT
NOK 19.15
7D
4.1%
1Y
-20.2%
Oncoinvent
Market Cap: NOK 136.3m
A clinical stage company, develops radiopharmaceutical therapies against cancer.
ONCIN
NOK 1.39
7D
-6.8%
1Y
n/a
Nykode Therapeutics
Market Cap: NOK 558.4m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 1.71
7D
-1.8%
1Y
-85.8%
Zelluna
Market Cap: NOK 300.7m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 14.70
7D
6.5%
1Y
n/a
Arctic Bioscience
Market Cap: NOK 98.6m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.
ABS
NOK 3.67
7D
-2.7%
1Y
-66.9%
SoftOx Solutions
Market Cap: NOK 242.0m
Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
SOFTX
NOK 0.11
7D
7.5%
1Y
191.9%
Navamedic
Market Cap: NOK 459.2m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 26.00
7D
10.6%
1Y
-12.8%